Going global
Nordic Life Science Days Nordic Life Science Days, the largest partnering opportunity of the year for the fast-growing Scandinavian life sciences industry, was recently held in Malmö, Sweden.
The meeting was located close to AstraZeneca’s former global respiratory and inflammation research site in Lund. Now called Medicon Village, it is linked via the Øresund bridge to companies and sites of scientific excellence in Denmark to create Medicon Valley, one of the leading life sciences clusters in Scandinavia. Alderley Park in Cheshire is another former AstraZeneca global research site turned science park, and is home to Aptus Clinical, an oncology focused
22
UK Lifescience Industry Magazine
clinical CRO. Since its formation in 2014, Aptus has experienced exponential growth and awardwinning recognition. So, what attracted Aptus to this Nordic conference? “The chance to reconnect with former AstraZeneca colleagues and meet so many innovative companies, who like us, are passionate in applying great science for the benefit of patients, was an opportunity not to miss”, said Jonathan Lewis, Business Development Director and co-founder. “Our aim is to help transform our client’s promising therapies into valued medicines by innovatively designing and expertly delivering clinical studies. Scientific innovation happens all over the globe, and we firmly believe that it’s partnering conferences like this that provide the perfect environment for us to meet potential collaborators’”
Jonathan is also convinced that the UK is the best country to conduct translational and early clinical research, and these events allow them to showcase the advantages the UK offers companies engaged in clinical development. “One of the presentations I attended during the conference examined how compounds that have been ‘parked’, despite having clinical potential, can be progressed to bring potential future patient benefits. The world leading academic expertise and research infrastructure, tax efficiencies and favorable regulatory environment in the UK make it the ideal location to support such research”, he added.
www.aptusclinical.com